CN108264491B - 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 - Google Patents
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 Download PDFInfo
- Publication number
- CN108264491B CN108264491B CN201611262335.6A CN201611262335A CN108264491B CN 108264491 B CN108264491 B CN 108264491B CN 201611262335 A CN201611262335 A CN 201611262335A CN 108264491 B CN108264491 B CN 108264491B
- Authority
- CN
- China
- Prior art keywords
- water
- acid
- added
- cyclen
- dota
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 title claims abstract description 110
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 216
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 claims abstract description 102
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000000047 product Substances 0.000 claims abstract description 33
- 239000002253 acid Substances 0.000 claims abstract description 28
- 238000005804 alkylation reaction Methods 0.000 claims abstract description 26
- 239000012043 crude product Substances 0.000 claims abstract description 23
- 239000011230 binding agent Substances 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 156
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 127
- 238000006243 chemical reaction Methods 0.000 claims description 83
- 239000000243 solution Substances 0.000 claims description 49
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 43
- 238000001035 drying Methods 0.000 claims description 36
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical group CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 claims description 36
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 claims description 36
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- 230000002378 acidificating effect Effects 0.000 claims description 24
- 239000003960 organic solvent Substances 0.000 claims description 24
- 238000001953 recrystallisation Methods 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000003002 pH adjusting agent Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 150000001340 alkali metals Chemical class 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 6
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical group OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 6
- 229940106681 chloroacetic acid Drugs 0.000 claims description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 229940071870 hydroiodic acid Drugs 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000011630 iodine Chemical group 0.000 claims description 2
- 229910052740 iodine Chemical group 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 239000002994 raw material Substances 0.000 abstract description 35
- 238000000746 purification Methods 0.000 abstract description 16
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 12
- 239000003456 ion exchange resin Substances 0.000 abstract description 12
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 12
- 238000009776 industrial production Methods 0.000 abstract description 4
- 239000012535 impurity Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000007710 freezing Methods 0.000 abstract description 2
- 230000008014 freezing Effects 0.000 abstract description 2
- 239000007787 solid Substances 0.000 description 119
- 238000004128 high performance liquid chromatography Methods 0.000 description 55
- 238000004809 thin layer chromatography Methods 0.000 description 48
- 238000010438 heat treatment Methods 0.000 description 47
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 238000001914 filtration Methods 0.000 description 17
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 6
- -1 organic acid salts Chemical class 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- 238000004537 pulping Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001728 nano-filtration Methods 0.000 description 4
- 229910052573 porcelain Inorganic materials 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 3
- 150000008041 alkali metal carbonates Chemical class 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000029219 regulation of pH Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- CPRMKOQKXYSDML-UHFFFAOYSA-M rubidium hydroxide Chemical compound [OH-].[Rb+] CPRMKOQKXYSDML-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- ZPDFIIGFYAHNSK-CTHHTMFSSA-K 2-[4,10-bis(carboxylatomethyl)-7-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) Chemical compound [Gd+3].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-CTHHTMFSSA-K 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 150000000921 Gadolinium Chemical class 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052730 francium Inorganic materials 0.000 description 1
- KLMCZVJOEAUDNE-UHFFFAOYSA-N francium atom Chemical compound [Fr] KLMCZVJOEAUDNE-UHFFFAOYSA-N 0.000 description 1
- 229960003411 gadobutrol Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- OHXYLFVFSUFWPO-UHFFFAOYSA-M lithium;2-chloroacetate Chemical compound [Li+].[O-]C(=O)CCl OHXYLFVFSUFWPO-UHFFFAOYSA-M 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- YQWBMBSWODTQFG-UHFFFAOYSA-M potassium;2-iodoacetate Chemical compound [K+].[O-]C(=O)CI YQWBMBSWODTQFG-UHFFFAOYSA-M 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- WPFGFHJALYCVMO-UHFFFAOYSA-L rubidium carbonate Chemical compound [Rb+].[Rb+].[O-]C([O-])=O WPFGFHJALYCVMO-UHFFFAOYSA-L 0.000 description 1
- 229910000026 rubidium carbonate Inorganic materials 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- SESSOVUNEZQNBV-UHFFFAOYSA-M sodium;2-bromoacetate Chemical compound [Na+].[O-]C(=O)CBr SESSOVUNEZQNBV-UHFFFAOYSA-M 0.000 description 1
- AGDSCTQQXMDDCV-UHFFFAOYSA-M sodium;2-iodoacetate Chemical compound [Na+].[O-]C(=O)CI AGDSCTQQXMDDCV-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (21)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611262335.6A CN108264491B (zh) | 2016-12-30 | 2016-12-30 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
JP2019556400A JP2020504175A (ja) | 2016-12-30 | 2017-09-18 | 1,4,7,10−テトラアザシクロドデカン−1,4,7,10−四酢酸の製造方法 |
US16/473,242 US11214553B2 (en) | 2016-12-30 | 2017-09-18 | Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
MX2019007798A MX2019007798A (es) | 2016-12-30 | 2017-09-18 | Metodo para preparar acido 1,4,7,10-tetraazaciclododecano-1,4,7,10 -tetraacetico. |
ES17889406T ES2865297T3 (es) | 2016-12-30 | 2017-09-18 | Método para la preparación de ácido 1,4,7,10-tetraazaciclododecano-1,4,7,10-tetraacético |
CA3048549A CA3048549C (en) | 2016-12-30 | 2017-09-18 | Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
PCT/CN2017/102056 WO2018120923A1 (zh) | 2016-12-30 | 2017-09-18 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
KR1020197021751A KR102265637B1 (ko) | 2016-12-30 | 2017-09-18 | 1,4,7,10-테트라아자시클로도데칸-1,4,7,10-테트라아세트산의 제조 방법 |
EP17889406.9A EP3564218B1 (en) | 2016-12-30 | 2017-09-18 | Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
CN201780080570.8A CN110198931B (zh) | 2016-12-30 | 2017-09-18 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611262335.6A CN108264491B (zh) | 2016-12-30 | 2016-12-30 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108264491A CN108264491A (zh) | 2018-07-10 |
CN108264491B true CN108264491B (zh) | 2022-09-16 |
Family
ID=62710288
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611262335.6A Active CN108264491B (zh) | 2016-12-30 | 2016-12-30 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
CN201780080570.8A Active CN110198931B (zh) | 2016-12-30 | 2017-09-18 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780080570.8A Active CN110198931B (zh) | 2016-12-30 | 2017-09-18 | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US11214553B2 (zh) |
EP (1) | EP3564218B1 (zh) |
JP (1) | JP2020504175A (zh) |
KR (1) | KR102265637B1 (zh) |
CN (2) | CN108264491B (zh) |
CA (1) | CA3048549C (zh) |
ES (1) | ES2865297T3 (zh) |
MX (1) | MX2019007798A (zh) |
WO (1) | WO2018120923A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108658882A (zh) * | 2017-03-28 | 2018-10-16 | 江苏恒瑞医药股份有限公司 | 一种1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 |
CN113087680A (zh) * | 2020-01-08 | 2021-07-09 | 威智医药有限公司 | Dota晶型及其制备方法 |
US20230248851A1 (en) * | 2020-06-10 | 2023-08-10 | Justesa Imagen S.A.U. | Procedure for obtaining gadoterate meglumine from high-purity tetraxetan (dota) and its use in the preparation of injectable galenical formulations |
CN113429362A (zh) * | 2021-06-01 | 2021-09-24 | 南昌大学 | 环胺高氯酸可逆相变材料及其制备方法 |
CN113956262B (zh) * | 2021-10-18 | 2023-03-07 | 苏州百灵威超精细材料有限公司 | 一种四氮杂环烷类化合物及其中间体的合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659702A (zh) * | 2012-04-09 | 2012-09-12 | 武汉工程大学 | 一种1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的纯化方法 |
CN105939994A (zh) * | 2014-02-06 | 2016-09-14 | 爱克发医疗保健公司 | 纯化1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1293777B1 (it) | 1997-07-25 | 1999-03-10 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
CA2833587A1 (en) * | 2011-04-20 | 2012-10-26 | Rf Therapeutics Inc. | Targeted contrast agents and uses thereof |
US10106489B2 (en) | 2011-11-25 | 2018-10-23 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the purification of polyaminocarboxylates |
CN104955822B (zh) | 2013-01-28 | 2018-03-13 | T2医药有限责任公司 | 制备1,4,7,10‑四氮杂环十二烷‑1,4,7,10‑四乙酸及其络合物的方法 |
CN104447598B (zh) | 2013-09-18 | 2017-09-22 | 浙江大德药业集团有限公司 | Ca‑4的大环多胺衍生物及其抗肿瘤特性 |
-
2016
- 2016-12-30 CN CN201611262335.6A patent/CN108264491B/zh active Active
-
2017
- 2017-09-18 WO PCT/CN2017/102056 patent/WO2018120923A1/zh unknown
- 2017-09-18 MX MX2019007798A patent/MX2019007798A/es unknown
- 2017-09-18 EP EP17889406.9A patent/EP3564218B1/en active Active
- 2017-09-18 ES ES17889406T patent/ES2865297T3/es active Active
- 2017-09-18 KR KR1020197021751A patent/KR102265637B1/ko active IP Right Grant
- 2017-09-18 CA CA3048549A patent/CA3048549C/en active Active
- 2017-09-18 US US16/473,242 patent/US11214553B2/en active Active
- 2017-09-18 CN CN201780080570.8A patent/CN110198931B/zh active Active
- 2017-09-18 JP JP2019556400A patent/JP2020504175A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659702A (zh) * | 2012-04-09 | 2012-09-12 | 武汉工程大学 | 一种1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的纯化方法 |
CN105939994A (zh) * | 2014-02-06 | 2016-09-14 | 爱克发医疗保健公司 | 纯化1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的方法 |
Non-Patent Citations (2)
Title |
---|
两种四乙酸四氮杂环烷化合物的合成;大塚齐之助 等;《广州化学》;19951231(第3期);第23页反应式、实验操作 * |
微波辐射技术在1, 4, 7, 10-四氮杂环十二烷四乙酸合成中的应用;扈艳红,等;《合成化学》;20071231;第15卷(第4期);第491-493页 * |
Also Published As
Publication number | Publication date |
---|---|
US20200347023A1 (en) | 2020-11-05 |
EP3564218B1 (en) | 2021-02-24 |
EP3564218A4 (en) | 2019-12-18 |
JP2020504175A (ja) | 2020-02-06 |
CN110198931B (zh) | 2022-08-02 |
CA3048549C (en) | 2023-11-21 |
ES2865297T3 (es) | 2021-10-15 |
KR102265637B1 (ko) | 2021-06-15 |
US11214553B2 (en) | 2022-01-04 |
CA3048549A1 (en) | 2018-07-05 |
KR20190098236A (ko) | 2019-08-21 |
EP3564218A1 (en) | 2019-11-06 |
CN110198931A (zh) | 2019-09-03 |
WO2018120923A1 (zh) | 2018-07-05 |
CN108264491A (zh) | 2018-07-10 |
MX2019007798A (es) | 2019-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108264491B (zh) | 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的制备方法 | |
CN111423452B (zh) | 瑞卢戈利的中间体及其制备方法和应用 | |
JP6096757B2 (ja) | 高純度ガドブトロールの製造 | |
NO317786B1 (no) | Ny form av irbesartan, fremgangsmate for a oppna den nevnte form og farmasoytiske preparater inneholdende den samme | |
EP2922860A2 (en) | Hydrated and anhydrous polymorphs of 2'-o-fucosyllactose and methods for their production | |
CN108084105B (zh) | 钆特醇中间体及其合成方法和利用该钆特醇中间体制备钆特醇的方法 | |
CN108440536B (zh) | 一种取代[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪类化合物及其制备 | |
CN109293592A (zh) | 一种制备钆布醇的方法 | |
CA2431976C (en) | Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use | |
JP2008538371A (ja) | シクレン誘導体の合成 | |
CN109336833B (zh) | 一种1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸的制备方法 | |
CN114890999B (zh) | 一种pqq的制备方法 | |
EP2900662A1 (en) | A method of preparing a highly pure potassium salt of azilsartan medoxomil | |
JP2016175938A (ja) | エピルビシン塩酸塩の結晶化 | |
JP2011519840A (ja) | 1,7’−ジメチル−2’−プロピル−2,5’−ビ−1h−ベンゾイミダゾールの製造 | |
CN115667222A (zh) | 一种制备glp-1受体激动剂的方法 | |
CN106866560B (zh) | 一种Lesinurad的合成方法 | |
CN113416121B (zh) | 一种磷丙泊酚钠及其中间体的合成方法与应用 | |
RU2703286C1 (ru) | Соли (5-гидрокси-3,4-бис(гидроксиметил)-6-метилпиридин-2-ил)метансульфокислоты и способ их получения | |
JP5412033B2 (ja) | 6,6’−(エチレンジオキシ)ビス−2−ナフトエ酸の精製方法 | |
EP1666471A1 (en) | Process for producing 2' -(1h-tetrazol-5-yl)-biphenyl-4-carbaldehyde | |
CN101811976A (zh) | 一种Nω-甲基赖氨酸的制备方法 | |
CN113087680A (zh) | Dota晶型及其制备方法 | |
CN114671793A (zh) | 4-(5,5-二羟甲基-2-氧吡咯烷基)-3-胍基亚甲基苯甲酸的制备方法 | |
JPS626543B2 (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 277514 No.88, Weizhi Avenue, Tengzhou biomedical industrial park, Zaozhuang City, Shandong Province Applicant after: Weizhi Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Applicant after: SHANDONG VIWIT BAIKE PHARMACEUTICAL CO.,LTD. Address before: 277500 88, Wei Zhi Avenue, biological medicine industry base, Tengzhou City, Zaozhuang, Shandong. Applicant before: VIWIT PHARMACEUTICAL Co.,Ltd. Applicant before: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Applicant before: SHANDONG VIWIT BAIKE PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 88 No. 277514 Shandong city of Zaozhuang province Tengzhou biological medicine industry base wise Avenue Applicant after: Weizhi Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Applicant after: SHANDONG VIWIT BAIKE PHARMACEUTICAL CO.,LTD. Address before: 277514 No.88, Weizhi Avenue, Tengzhou biomedical industrial park, Zaozhuang City, Shandong Province Applicant before: Weizhi Pharmaceutical Co.,Ltd. Applicant before: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Applicant before: SHANDONG VIWIT BAIKE PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 88, Weizhi Avenue, biomedical industrial park, Tengzhou City, Zaozhuang City, Shandong Province, 277500 Patentee after: Weizhi Pharmaceutical Co.,Ltd. Patentee after: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Patentee after: SHANDONG VIWIT BAIKE PHARMACEUTICAL CO.,LTD. Address before: 277514 No. 88 Weizhi Avenue, Tengzhou Biomedical Industry Base, Zaozhuang City, Shandong Province Patentee before: Weizhi Pharmaceutical Co.,Ltd. Patentee before: SHANGHAI VIWIT PHARMACEUTICAL Co.,Ltd. Patentee before: SHANDONG VIWIT BAIKE PHARMACEUTICAL CO.,LTD. |
|
CP03 | Change of name, title or address |